Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group

Aim. To study the course of COVID-19 (COronaVIrus Disease 2019) in elderly patients with acute myeloid leukemia (AML), to analyze risk factors for unfavorable outcome.Materials and methods. The paper presents our own experience in the treatment of elderly (age ≥65 years) patients with AML and concom...

Full description

Saved in:
Bibliographic Details
Main Authors: L. T. Shimanovskaya, E. N. Misyurina, E. A. Baryakh, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, A. B. Makeshova, M. A. Mingalimov, D. D. Ivanova, O. L. Kochneva, E. N. Zotina, T. N. Tolstykh, E. Yu. Grishina, D. E. Gagloeva, Yu. Yu. Polyakov, V. N. Yakimets, A. I. Koneva
Format: Article
Language:Russian
Published: ABV-press 2024-01-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/892
Tags: Add Tag
No Tags, Be the first to tag this record!